Efficacy and safety of Melaleuca alternifolia (tea tree) oil for human health—A systematic review of randomized controlled trials
Frontiers in Pharmacology · 6 authors, 2 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The review found that while the evidence base has expanded substantially, many trials suffered from inadequate reporting of tea tree oil source and quality, limiting the certainty of efficacy and safety conclusions.
Full summary
928 CHARS
This prospectively registered systematic review (PROSPERO CRD42021285168) screened 974 records and included 46 RCTs across dentistry, dermatology, infectious disease, ophthalmology, podiatry, and anxiety/sleep quality. Key limitations included inadequate reporting of tea tree oil source and quality in many trials, difficulty blinding participants due to the oil's strong aroma, heterogeneous product formulations, and lack of adverse event assessment in most trials. Safety concerns included reports that 17% of adverse events due to essential oil exposure were caused by tea tree oil, and that oxidized tea tree oil is the primary driver of sensitization and skin irritation. The authors concluded that future rigorous trials are warranted for acne, molluscum contagiosum, microbial causes of tooth decay, periodontal disease, oral fungal conditions, antibiotic-resistant bacterial infections, and ocular Demodex infestation.